Dr Ashok Sharma's Cornea Centre, Chandigarh, India.
Indian J Ophthalmol. 2021 Feb;69(2):438-440. doi: 10.4103/ijo.IJO_1379_20.
A 78.year.old male underwent ultra.thin DSAEK for PBK (OS) and achieved BCVA 6/12 at 9 months. The patient developed allograft rejection 10 months postoperatively and was treated with IV methyl prednisolone, systemic, and topical steroids. The patient then improved and achieved 6/18 BCVA at 8 weeks. Topical prednisolone 1% twice daily was continued. Six weeks later, the patient developed fever and diminished vision and had high IOP, corneal edema, and keratic precipitates on endothelium. Considering it to as second episode of graft rejection, IV methyl prednisolone and topical steroids were given. Seeing no response, presumed HSV endotheliitis was considered as diagnosis and treated with steroids, oral acyclovir. The patient improved and achieved BCVA 6/24 with no subsequent recurrence during 11 months follow.up.
一位 78 岁男性患者因 PK(OS)而行超微 DSAEK,术后 9 个月达到 BCVA 6/12。术后 10 个月患者发生同种异体排斥反应,给予 IV 甲基强的松龙、全身和局部皮质类固醇治疗。患者随后好转,8 周时达到 BCVA 6/18。继续局部使用 1%强的松龙每日两次。6 周后,患者出现发热和视力下降,眼压升高,角膜水肿,内皮有角膜后沉着物。考虑为第二排斥反应发作,给予 IV 甲基强的松龙和局部皮质类固醇治疗。未见反应,考虑为单纯疱疹病毒内皮炎,给予皮质类固醇、口服阿昔洛韦治疗。患者好转,BCVA 达到 6/24,随访 11 个月无再次复发。